InTrack Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,140
Closed -$473K 130
2023
Q2
$473K Buy
6,140
+2,162
+54% +$167K 0.39% 84
2023
Q1
$297K Sell
3,978
-61
-2% -$4.54K 0.27% 103
2022
Q4
$318K Sell
4,039
-75
-2% -$5.62K 0.32% 89
2022
Q3
$289K Sell
4,114
-100
-2% -$7.84K 0.32% 88
2022
Q2
$338K Sell
4,214
-596
-12% -$46.6K 0.35% 84
2022
Q1
$365K Buy
4,810
+695
+17% +$55.1K 0.3% 91
2021
Q4
$351K Sell
4,115
-90
-2% -$7.03K 0.24% 99
2021
Q3
$319K Buy
+4,205
New +$334K 0.23% 99

Other funds holding CL

InTrack Investment Management's CL Position: Q3 2023 in Review

InTrack Investment Management sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 6,140 shares — an estimated $473K sold.

InTrack Investment Management first reported a position in CL in Q3 2021 and held it in 8 quarters. The position peaked at $473K in Q2 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • InTrack Investment Management reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • InTrack Investment Management sold 6,140 Colgate-Palmolive shares in Q3 2023, an estimated $473K.
  • InTrack Investment Management first reported a position in Colgate-Palmolive in Q3 2021 and held it in 8 quarters.
  • InTrack Investment Management's Colgate-Palmolive position peaked at $473K in Q2 2023.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on InTrack Investment Management's 13F filing for Q3 2023, filed 20 Oct 2023.